OpenAlex
PricingAboutJobs
Log inGet started
Work

Discovery of SARS-CoV-2 PLpro covalent inhibitors enabled by a novel reversible covalent chloroalkyne warhead

HTML

Year: 2026
Type: article
Source: Bioorganic & Medicinal Chemistry
DOI: 10.1016/j.bmc.2026.118792
Authors: Divakar Indukuri, Jazmin Galván Achi, Boopathi Sownthirarajan, Malla Reddy Gannarapu, Omar Lozano Ramos, Kiira Ratia, Priyajit Kaur, Rishi Vardhan Chunduru, Zuohuang Qi, Paulina Anguiano, Balaji Manicassamy, Lijun Rong, Rui Xiong
Institutions: University of Arizona, University of Illinois Chicago, University of Iowa
Language: English

Topic: SARS-CoV-2 and COVID-19 Research
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: SARS-CoV-2, papain-like protease, covalent inhibitors, cysteine protease inhibitors, glutathione reactivity, antiviral drug discovery, linker design, cathepsin B, calpain
SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute of Allergy and Infectious Diseases
Award: Targeting SARS-CoV-2 PLpro for COVID-19 treatment
OpenAlex ID: W7204665307
FWCI:
Cites: 54
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security